FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

2,253 letters match. Newest first.

  1. Newman Clinic, PLLC dba Newman Clinic

    FDA told Newman Clinic its website misbranded compounded semaglutide and tirzepatide with false and misleading claims.

    Medium
  2. NewSelf Limited dba NewSelf

    FDA warns NewSelf over misleading website claims for compounded semaglutide and tirzepatide, including false compounder and FDA-approval implications.

    Low
  3. 24HrDoc, Inc. dba 24HrDoc

    FDA says 24HrDoc's website misbrands compounded semaglutide and tirzepatide with false claims that it compounds them and that they match Ozempic, Wegovy, Mounjaro, Zepbound.

    Medium
  4. Alan Health Technologies Inc. dba Alan

    FDA warns Alan Health Technologies over website falsely labeling compounded semaglutide and tirzepatide as Alan-made.

    Low
  5. Dripgym Mobile Parent, LLC dba Amp Health

    FDA warned Amp Health that its website misbranded compounded semaglutide and tirzepatide with false maker and approval-implying claims.

    Low
  6. Belle Health LLC dba Belle

    FDA warned Belle Health that its website falsely suggests Belle compounds semaglutide and tirzepatide, making the drugs misbranded.

    Low
  7. Bliv Wellness LLC dba Bliv

    FDA warns Bliv Wellness that its website falsely suggests it compounds semaglutide and tirzepatide, making the drugs misbranded.

    Medium
  8. BluefitMD

    FDA warned BluefitMD that its website falsely labels compounded semaglutide and tirzepatide as its own and as FDA-approved.

    Low
  9. Deluxe IV Aesthetics PLLC dba Deluxe IV and Aesthetics

    FDA warned Deluxe IV and Aesthetics over misleading website claims for compounded semaglutide and tirzepatide, including implying FDA approval.

    Low
  10. Aspen Aesthetics dba Fifty 410

    FDA warns Fifty 410 over misleading website claims for compounded semaglutide and tirzepatide, including implied compounding and 'clinically proven' claims.

    Low
  11. FitRX, LLC dba FitRx

    FitRx's website misbranded compounded semaglutide and tirzepatide with false and misleading claims, FDA says.

    Medium
  12. Genesis Health International Inc. dba Genesis

    FDA warns Genesis over misleading website claims for compounded semaglutide and tirzepatide.

    Low
  13. Diasol, Inc.

    Diasol sold unapproved citric acid hemodialysis disinfectants and had quality system violations, FDA says.

    High risk
  14. The Sabagh Group Inc/lighterusa.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  15. swedishproducts.online

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  16. Dynamic Stem Cell Therapy

    FDA warned Dynamic Stem Cell Therapy that its umbilical cord-derived stem cell product is an unapproved, unlicensed, misbranded biological drug.

    High risk
  17. ExThera Medical Corporation

    ExThera shipped Seraph 100 blood filters for compassionate use without FDA approval and promoted them as approved.

    High risk
  18. Beta Bionics, Inc.

    FDA says Beta Bionics' iLet Bionic Pancreas system had quality-system failures, including ignored complaints of severe hypoglycemia and diabetic ketoacidosis.

    High risk
  19. Tombak LLC

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  20. MedisourceRx

    MedisourceRx failed to report a serious adverse event and had inadequate procedures, so its compounded drugs lost legal exemptions.

    Medium
  21. Elanco Animal Health USA

    FDA says Elanco's Pradalex ads misbrand the livestock antibiotic by claiming first-line use and "all relevant pathogen" coverage.

    Medium
  22. ProDx Health

    FDA warns ProDx Health that its HIV sample self-collection kits are sold without marketing authorization.

    High risk
  23. niqpouches.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  24. BNC Distribution Inc.

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  25. gotpouches.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  26. CC Pollen Company

    FDA warns CC Pollen Company of Glendale, Arizona, that its bee pollen and royal jelly supplements are adulterated and misbranded.

    High risk
  27. Eniva USA, Inc.

    FDA warns Eniva USA over manufacturing quality failures for Immune Support and Ashwagandha Gummies.

    Medium
  28. Germaphobix

    FDA warns Germaphobix that its unapproved HIV dried blood spot self-collection kit is adulterated and misbranded.

    High risk
  29. Prodrome Sciences USA, LLC

    Prodrome Sciences studied its supplement ProdromeNeuro Oil as a dementia drug in 29 people without first filing an IND, FDA says.

    High risk
  30. Genetrace

    FDA warned Genetrace that its HIV dried blood spot self-collection kit is unapproved and misbranded.

    High risk
  31. Genovate

    FDA warns Genovate over selling an unapproved HIV dried-blood-spot self-collection kit without marketing authorization.

    High risk
  32. LXR Biotech, LLC

    FDA warns LXR Biotech over CGMP (manufacturing quality rules) failures for Eternal Energy supplements, making them adulterated (legally unfit as made).

    Medium
  33. ASP Global, LLC. dba Anatomy Supply Partners, LLC.

    FDA cites ASP Global for quality-system, reporting, and unapproved-change violations involving Safe-T-Fill blood collection devices.

    High risk
  34. Pan-African Food Distributors Inc./East Africa Boutique LLC

    FDA found widespread rodent and insect infestation in Pan-African Food Distributors’ warehouse holding dietary supplements, foods and cosmetics.

    High risk
  35. snuzyn.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  36. bongsociety.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  37. Agebox Inc.

    Agebox Inc. sells iKids-Growth children's supplements containing the undeclared, unapproved drug ibutamoren, making them unapproved and misbranded drugs.

    High risk
  38. Private Label Skin Care, Inc.

    FDA warned Private Label Skin Care about poor quality oversight, continued sale of impurity-affected over-the-counter drugs, and missing drug listings.

    High risk
  39. smokespotvape.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  40. Darmerica, LLC

    FDA warns Darmerica over manufacturing-quality violations and mislabeled drug ingredients, including retatrutide.

    High risk
  41. TG Supply LLC d/b/a TransGuy Supply

    FDA warned TransGuy Supply that its breast binders are unregistered, unlisted medical devices.

    Low
  42. Flux Lab Pte. Ltd. d/b/a The Fluxion

    FDA warns Flux Lab/The Fluxion over unregistered, unlisted chest binders marketed as medical devices.

    Medium
  43. Marli Washington Design, LLC

    Marli Washington Design (gc2b) sold breast binders as medical devices without FDA registration or listing for FY2026, making them misbranded.

    Low
  44. FLAVNT Streetwear, LLC

    FDA says FLAVNT Streetwear sold breast binders as medical devices without registering or listing them for fiscal 2026.

    Low
  45. Early to Bed, Inc.

    FDA warned Early to Bed, Inc. that its breast binders are misbranded because the manufacturer was not registered or listed with FDA.

    Low
  46. GenderBender LLC

    GenderBender LLC sells breast binders as medical devices without FDA registration or listing, making them misbranded.

    Low
  47. TomboyX, PBC

    FDA says TomboyX sells breast binders as medical devices without registering or listing them, making them misbranded.

    Medium
  48. Philadelphia 7, Inc d/b/a Passional Boutique

    FDA says Philadelphia 7 sold unregistered, unlisted breast binders, making them misbranded devices.

    Low
  49. TOMSCOUT

    FDA says TOMSCOUT sells breast binders as medical devices without required FDA registration or listing.

    Low
  50. For Them, Inc.

    FDA says For Them, Inc. sells breast binders as unregistered medical devices, making them misbranded.

    Low